Nova Mentis Life Science Corp (NOVA.CX)
0.015
0.00 (0.00%)
CAD |
CNSX |
Apr 29, 16:00
Nova Mentis Life Science Profit Margin (Quarterly): -649.3% for Sept. 30, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | -649.3% |
March 31, 2023 | |
December 31, 2022 | |
September 30, 2022 | |
June 30, 2022 | |
March 31, 2022 | |
December 31, 2021 | |
September 30, 2021 | |
June 30, 2021 | |
March 31, 2021 | |
December 31, 2020 | -1.18M% |
September 30, 2020 | -42.10K% |
June 30, 2020 | -380.9K% |
March 31, 2020 | -2.65K% |
December 31, 2019 | -3.48K% |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | |
September 30, 2017 | |
June 30, 2017 |
Date | Value |
---|---|
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | |
September 30, 2011 | |
June 30, 2011 | |
March 31, 2011 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.18M%
Minimum
Dec 2020
-649.3%
Maximum
Sep 2023
-269.0K%
Average
-22.79K%
Median
Profit Margin (Quarterly) Benchmarks
Biocure Technology Inc | -- |
Core One Labs Inc | -897.6% |
Nanosphere Health Sciences Inc | -- |
Lobe Sciences Ltd | -417.0% |
Algernon Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -747.9% |
Return on Assets | -351.9% |
Return on Invested Capital | -747.9% |
Operating Margin (Quarterly) | -672.7% |
Return on Net Operating Assets | -763.9% |